SCHEMBL26933825

SCHEMBL26933825

O=C(NC1CCNC1)N1CCN(C2CCCCC2)c2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ TSHR P16473 1/20 0.49
▸ NPC1 O15118 1/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ P2RX1 P51575 1/20 0.40
▸ P2RX3 P56373 1/20 0.40
▸ P2RX4 Q99571 1/20 0.40
▸ P2RX7 Q99572 1/20 0.40
▸ GPBAR1 Q8TDU6 4/20 0.39
▸ BCHE P06276 2/20 0.39
▸ MAPT P10636 5/20 0.39
▸ TP53 P04637 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ HRH3 Q9Y5N1 1/20 0.38
▸ HTR2C P28335 2/20 0.38
▸ HTR2B P41595 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26933820 1.00 SMN1; SMN2 (0.49) SMN1; SMN2TSHRNPC1RAB9AP2RX1
SCHEMBL30673726 1.00 SMN1; SMN2 (0.49) SMN1; SMN2TSHRNPC1RAB9AP2RX1
SCHEMBL30673822 0.89 TSHR (0.40) SMN1; SMN2TSHRNPC1RAB9AP2RX4
SCHEMBL31506827 0.89 TSHR (0.40) SMN1; SMN2TSHRNPC1RAB9AP2RX4
SCHEMBL30673772 0.80 SMN1; SMN2 (0.49) SMN1; SMN2TSHRNPC1RAB9AP2RX1
SCHEMBL30673698 0.80 SMN1; SMN2 (0.49) SMN1; SMN2TSHRNPC1RAB9AP2RX1
SCHEMBL26933899 0.79 SMN1; SMN2 (0.48) SMN1; SMN2TSHRNPC1RAB9AP2RX1
SCHEMBL26933904 0.79 SMN1; SMN2 (0.48) SMN1; SMN2TSHRNPC1RAB9AP2RX1
SCHEMBL30673881 0.78 SMN1; SMN2 (0.47) SMN1; SMN2TSHRNPC1RAB9AP2RX1
SCHEMBL30673689 0.76 BRD4 (0.54) SMN1; SMN2TSHRNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4538270-A1 NOVEL COMPOUND, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT Sapiensbio Inc. (KR) 2025-04-16 — — EP claimed
EP-4538270-A1 NOVEL COMPOUND, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT Sapiensbio Inc. (KR) 2025-04-16 — — EP disclosed
WO-2023239227-A1 NOVEL COMPOUND, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT 주식회사 사피엔스바이오 2023-12-14 — — WO disclosed
Send feedback